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In neuroendocrine cells, hormones and neuropeptides are released from large-dense core vesicles (secretory 
granules) by calcium-regulated exocytosis. Following exocytosis, compensatory uptake of membrane is required 
to maintain membrane homeostasis and allow recycling of secretory vesicle membranes. How these cells initiate 
and regulate this compensatory endocytosis remains poorly understood. Our recent data suggests that 
oligophrenin-1 (OPHN1) is a link coupling calcium-regulated exocytosis to compensatory endocytosis of 
secretory granules in the adrenal chromaffin cells (Houy et al., 2015, J Neurosci. 2015, 35:11045-55). Here, we 
highlight the major evidence and discuss how OPHN1 could couple these two processes. 
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Introduction 
Intracellular membrane trafficking along endocytotic and 
secretory pathways plays a critical role in diverse cellular 
functions including developmental and pathological 
processes. Proteins and lipids destined for transport to 
distinct locations are collectively assembled into vesicles and 
delivered to their target site by vesicular fission and fusion. 
Although much has been learned concerning these 
mechanisms at donor and acceptor compartments, relatively 
little attention has been paid to understanding how membrane 
homeostasis is preserved. This aspect is particularly 
important in neurosecretory cells in which intense membrane 
trafficking and mixing occur between the plasma membrane 
and secretory vesicle membranes during neurotransmission 
and hormone release. 
In neuroendocrine cells, hormones and neuropeptides are 
stored in large dense-core vesicles (LDCV), the secretory 
granules. Exocytotic release of hormones and neuropeptides 
into the blood stream involves four main trafficking steps: i) 
the tethering of granules to the plasma membrane, ii) their 
docking at the exocytotic sites through the assembly of 
SNARE proteins, iii) the priming step rendering the docked 
granules competent for fusion and iv) the fusion between the 
granule membrane and the plasma membrane leading to the 
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formation of a fusion pore that expands to release the granule 
content. While the mechanisms underlying exocytosis per se 
have been extensively characterized in neuroendocrine cells, 
how the composition, integrity and functionality of the 
plasma membrane are maintained after exocytosis is obscure. 
However, in neuroendocrine chromaffin cells from the 
adrenal gland, we have proposed that secretory granule 
proteins cluster together at the plasma membrane after full 
fusion exocytosis before their recapture by compensatory 
endocytosis[1]. One of our current research goals is to 
determine the molecular machinery that enables this sorting, 
segregation and recapture of secretory granule membrane 
components.  
The characteristics of oligophrenin-1 (OPHN1, figure 1) 
attracted our attention and suggested it might be a potential 
candidate for linking the exocytosis and endocytosis in 
chromaffin cells. OPHN1 was originally discovered as one of 
the genes implicated in cognitive dysfunctions [2], and has 
previously been shown to regulate membrane trafficking 
events linked to synaptic functions, including plasticity, 
post-synaptic receptor trafficking, and synaptic vesicle 
recycling [3-9]. It is a multi-domain protein which can interact 
with membranes through a BAR domain affecting membrane 
curvature and Pleckstrin Homology (PH) domain which 
facilitates membrane binding. In addition, OPHN1 is a 
GTPase activating protein (GAP) of the Rho-family [2] and 
can also interact directly with cytoskeleton actin filaments 
and with scaffold proteins with SH3 domains [10]. All these 
particular features prompted us to examine the role of 
OPHN1 in exo-endocytosis in chromaffin cells. 
Oligophrenin-1, a new actor in calcium-regulated 
exocytosis 
OPHN1 was found to be expressed in adrenal medulla 
tissue and was localized in the plasma membrane and in the 
cytoplasm of the adrenal chromaffin cells. Amperometric 
measurements of catecholamine secretion from cultured 
chromaffin cells from Ophn1 knock-out mice and from 
cultured bovine chromaffin cells with knocked down OPHN1 
expression revealed that the fusion pore formation is 
perturbed in the absence of OPHN1. In the bovine 
chromaffin cells, this phenotype could be rescued by 
re-expressing OPHN1, but not the GAP-dead OPHN1 mutant 
(OPHN1R409L), indicating that inactivation of a Rho-GTPase 
by OPHN1 is necessary for fusion pore formation. OPHN1 
probably specifically inactivates RhoA during exocytosis 
because knocking down OPHN1 only significantly increased 
the level of activated RhoA in stimulated PC12 cells. 
Several hypotheses can be proposed to explain how 
OPHN1 and the RhoA pathways contribute to formation of 
the fusion pore (figure 2). One possibility is that OPHN1 
regulates SNARE complex formation during exocytosis via 
the RhoA/Rho-kinase (ROCK) pathway. Indeed, 
deregulation of SNARE complex formation impacts fusion 
pore formation [11-13]. ROCK-induced phosphorylation of the 
t-SNARE syntaxin-1A favors its interaction with tomosyn, a 
negative regulator of secretion [14]. Therefore, OPHN1 may 
prevent the interaction between syntaxin-1A and tomosyn by 
inactivating RhoA/ROCK and thereby enhances the 
formation of the fusion pore. In neurons which express 
OPHN1 both pre- and post-synaptically, the role of OPHN1 
has been studied. While a direct function of OPHN1 in  
Figure 1. Schematic representation of Oligophrenin-1. OPHN1 is a Rho family GTPase activating protein (Rho-GAP) that contains a 
N-terminal BAR domain, which senses and binds curved membranes and a Pleckstrin Homology (PH) domain, which binds phosphatidylinositol 
lipids. The catalytic GAP domain inhibits RhoA, Rac1, and Cdc42 in vitro [2]. Moreover, at the C-terminal part, OPHN1 contains an actin-binding 
site and three Proline-rich sites permitting the interaction with SH3 domain containing proteins including amphiphysinI and II, CIN85, 
endophilinA1 and B2, Homer1 and intersectin1 [5, 7, 8, 28].  
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neurotransmitter release has not clearly been explored, two 
studies suggest that it might be the case. It has been shown in 
hippocampal neurons from Ophn1 knock-out mice that the 
size of the readily releasable pool is reduced and that 
short-term plasticity like paired-pulse facilitation is altered 
suggesting defects in vesicle availability for exocytosis and 
the probability of neurotransmitter release [3, 9]. In our study, 
the number of released vesicle was slightly reduced in KO 
chromaffin cells. However, carbon-fiber amperometry does 
not provide any indication about the size of the different 
vesicular pools. To obtain further information about vesicle 
pool sizes in these cells, capacitance measurements 
combined with carbon-fiber amperometry are required.  
Alternatively, OPHN1 may modulate the remodeling of 
the actin cytoskeleton which occurs during exocytosis. Not 
only can OPHN1 interact directly with actin filaments but the 
RhoA/ROCK pathway is known to regulate the acto-myosin 
contraction by enhancing myosin light chain phosphorylation 
either directly or through the activity of the myosin light 
chain phosphatase [15, 16]. Accordingly, modulation of the 
acto-myosin activity is known to affect fusion pore properties 
[17-19]. Moreover, previous studies from our laboratory 
demonstrated that inactivation of granule-bound RhoA 
during exocytosis is linked to the organization of the cortical 
actin network in chromaffin cells [20-22]. Subsequently, 
activation of the Rho-GTPase Cdc42 was shown to enhance 
de novo polymerization of actin filaments at granule docking 
sites [23] and annexin-A2 has recently been reported to bundle 
actin filaments in order to connect the granule membrane 
with the plasma membrane and regulate the fusion pore 
dynamics [24]. It is tempting to propose that OPHN1-induced 
Figure 2. Hypothetical model for the role of OPHN1 in exocytosis in chromaffin cells. In resting condition, the GAP domain of OPHN1 is 
non-functional which maintains active the granule-bound RhoA. Activated-RhoA might activate its downstream effector, the Rho-kinase (ROCK) 
that subsequently phosphorylates tomosyn enhancing the interaction between syntaxin-1 and tomosyn and restricting the formation of SNARE 
complex (VAMP-2/Syntaxin-1/SNAP25). In secretagogue-stimulated chromaffin cells, the rise in cytosolic calcium somehow triggers the 
activation of the OPHN1 GAP activity and the subsequent inactivation of RhoA. How inactivation of RhoA is linked to fusion pore formation is 
currently unknown. Inhibition of the RhoA-ROCK pathway might favor the SNARE complex formation by preventing tomosyn/syntaxin-1 
interaction. Alternatively, it might regulate the level of myosin light chain (MLC) phosphorylation and therefore modulate the myosin-induced 
forces required for exocytosis [32]. These two hypotheses are not mutually exclusive and required further investigations.  
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inhibition of RhoA is somehow required in this sequence of 
molecular events. For example, the interaction of OPHN1 
with F-actin might allow the specific recruitment of OPHN1 
at docking sites in order to inactivate granule-bound RhoA. 
This inactivation of RhoA could in turn prevent myosin light 
chain phosphorylation by ROCK, thus modifying the forces 
generated by the annexin-A2-induced bundles of filament at 
the interface between the granule and plasma membranes and 
affect fusion pore properties.  
Oligophrenin-1 regulates compensatory endocytosis of 
secretory granules 
Using an assay developed in our laboratory to specifically 
follow the granule membrane recapture after exocytosis (for 
more details see [1]), we observed a severe decrease (around 
70%) of the compensatory endocytosis in chromaffin cells 
cultured from Ophn1 KO mice. This reveals a major role of 
OPHN1 in the pathway mediating compensatory endocytosis 
of the secretory granule membrane. We then demonstrated 
that overexpression of OPHN1 mutant lacking the BAR 
domain reproduced the inhibitory effect on granule 
membrane recapture in bovine chromaffin cells whereas the 
GAP-dead OPHN1R409L mutant had no effect. These data 
indicate that the BAR domain of OPHN1 is essential for 
compensatory endocytosis in chromaffin cells.  
The role of OPHN1 in secretory granule recapture is easier 
to correlate with the data obtained in neurons. OPHN1 is 
pivotal in neurons for synaptic vesicle recycling or 
post-synaptic receptor endocytosis [5, 7, 25], yet surprisingly, 
the potential implication of the BAR domain of OPHN1 in 
these processes has never been questioned. On the contrary, 
it has been shown that OPHN1 is able to recruit and interact 
with other BAR domain-containing proteins involved in 
endocytosis: endophilinA1, endophilinB2 and amphiphysin 
[5, 7]. Moreover, an interaction between OPHN1 and 
endophilinA1 has been proposed to be essential for synaptic 
vesicle recycling [7]. This clearly raises an issue regarding the 
exact function of the BAR domain of OPHN1 at synapses. 
For the moment, the mechanisms by which OPHN1 regulates 
compensatory endocytosis in chromaffin cells are open to 
speculation.  
In order to bind and stabilize precise membrane curvature, 
BAR domains need to form homo- or hetero-dimers leading 
to the formation of a banana shape. Since the interaction with 
other BAR-domain containing proteins occurs through the 
C-terminal proline-rich domain of OPHN1, formation of 
hetero-dimers of BAR domains is a possibility. Whether such 
a conformation occurs in neurons and/or chromaffin cells 
requires further investigation. OPHN1 could also act as a 
scaffold protein by recruiting other functional proteins at the 
place where membranes are curved; in this case where the 
vesicle will be endocytosed [26, 27]. For example, we have 
previously shown that OPHN1 can interact with intersectin1 
(ITSN1) in neuroendocrine cells, a key regulator of 
endocytosis [28].  
Conclusion: Oligophrenin-1 is a molecular switch 
between exocytosis and endocytosis of secretory granules 
Altogether, these results clearly demonstrate a role for 
OPHN1 in the molecular machinery underlying 
neuroendocrine secretion. In particular, OPHN1 has a 
bifunctional role both in calcium-regulated exocytosis and 
compensatory endocytosis. However, an important remaining 
question is how does OPHN1 switch from its GAP activity 
required for exocytosis to its BAR activity required for 
compensatory endocytosis? Interestingly, the BAR domain 
itself can interact with the GAP domain leading to the 
inhibition of the GAP domain [10, 29]. In addition, interaction 
between the GAP and BAR domains seems to potentiate the 
BAR-mediated ability of membrane binding [29]. An 
attractive scenario can therefore be considered. OPHN1 is 
recruited to the exocytotic site in an “open conformation” 
and regulates fusion pore formation through its Rho-GAP 
activity. Once the intra-granular contents are released, 
OPHN1 shifts to an auto-inhibited conformation which 
blocks the GAP activity and enhances the activity of the 
BAR domain required for endocytosis. How the BAR 
domain binds to the GAP domain and how the switch from 
one conformation to the other is regulated requires further 
investigations.  
To conclude, OPHN1 functions as a structural checkpoint 
that spatially and temporally couples exocytosis and 
endocytosis in neuroendocrine cells, and appears as a good 
candidate to ensure a fine tuning of hormone secretory 
activity. The next challenges will be to decipher the 
mechanisms by which OPHN1 regulates fusion pore 
dynamics and to further explore the importance of the 
OPHN1 BAR domain in endocytic processes. Genetic 
mutations in OPHN1 gene leading either to the deletion of 
the BAR domain or to a non-functional BAR domain have 
recently been reported in patient with an intellectual 
disability [30, 31]. Along this same line, it would be of primary 
interest to investigate whether, patients with mutations in the 
OPHN1 gene display neuroendocrine disorders in addition to 
neuronal defects and associated cognitive disabilities.  
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